Profile data is unavailable for this security.
About the company
Molecure SA, formerly known as Oncoarendi Therapeutics SA, is a Poland-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
- Revenue in PLN (TTM)5.11m
- Net income in PLN-24.42m
- Incorporated2017
- Employees71.00
- LocationMolecure SAZwirki I Wigury 101WARSZAWA 02-089PolandPOL
- Phone+48 225526724
- Websitehttps://molecure.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GENOMED SA | 27.49m | 3.27m | 36.47m | 53.00 | 11.15 | 2.93 | 9.05 | 1.33 | 2.48 | 2.48 | 20.81 | 9.42 | 2.21 | 5.17 | 12.68 | 509,166.10 | 26.31 | 7.51 | 28.79 | 8.81 | 65.24 | 62.33 | 11.90 | 3.84 | 7.51 | -- | 0.00 | -- | 2.34 | 3.18 | 19.32 | 1.98 | 15.97 | -- |
| Sygnis SA | 9.81m | 2.56m | 43.88m | 12.00 | 14.23 | 1.27 | 9.63 | 4.47 | 0.1124 | 0.1124 | 0.4315 | 1.26 | 0.1813 | 0.4305 | 3.21 | -- | 4.72 | -6.31 | 6.82 | -8.93 | 88.66 | 64.29 | 26.06 | -30.82 | 0.9722 | 5.62 | 0.126 | -- | 30.62 | 28.56 | 122.65 | 53.12 | -- | -- |
| Sds Optic SA | 3.02m | -3.02m | 48.51m | 41.00 | -- | 40.24 | -- | 16.04 | -0.5058 | -0.5058 | 0.5020 | 0.1913 | 0.179 | 20.36 | 12.25 | -- | -17.98 | -31.44 | -18.90 | -34.79 | 91.17 | 57.78 | -100.39 | -122.69 | 2.42 | -2.51 | -- | -- | -31.78 | 303.14 | 40.23 | -- | -- | -- |
| Read Gene SA | 15.57m | 808.32k | 64.85m | 11.00 | 75.61 | 16.96 | 51.49 | 4.17 | 0.0727 | 0.0727 | 1.39 | 0.3243 | 1.04 | 10.34 | 4.23 | -- | 5.38 | -1.82 | 5.97 | -2.00 | 93.56 | 91.12 | 5.19 | -2.66 | 7.52 | 3.15 | -- | -- | 17.67 | 20.73 | 172.75 | 18.28 | 37.45 | -- |
| Genomtec SA | 15.00k | -11.01m | 68.24m | -- | -- | 6.59 | -- | 4,549.52 | -0.7485 | -0.7485 | 0.001 | 0.6869 | 0.0009 | -- | 0.0143 | -- | -65.47 | -89.96 | -82.11 | -113.38 | -54,120.00 | -4,379.72 | -73,393.34 | -17,225.07 | 2.82 | -39.82 | 0.1409 | -- | 0.00 | -63.42 | -24.35 | -- | -34.54 | -- |
| Hyenergy SA | 3.29m | 169.85k | 77.91m | 27.00 | -- | 3.95 | 318.90 | 23.69 | -0.0936 | -0.0936 | 0.1654 | 0.5878 | 0.1821 | 0.1259 | 0.7741 | -- | 0.9403 | 2.39 | 1.28 | 3.35 | 99.70 | 77.46 | 5.16 | 3.11 | 1.30 | 1.17 | 0.00 | -- | 192.83 | 19.47 | 100.30 | -- | -45.79 | -- |
| Nanogroup SA | -6.90k | -6.93m | 84.04m | -- | -- | 7.21 | -- | -- | -0.1844 | -0.1844 | -0.0002 | 0.3553 | -0.0003 | 2.64 | -- | -- | -30.59 | -29.50 | -51.55 | -33.80 | -- | 66.72 | -- | -2,258.26 | 0.9785 | -464.18 | 0.00 | -- | 3.96 | -64.09 | 34.50 | -- | 3.07 | -- |
| Urteste SA | 0.00 | -5.47m | 85.46m | 34.00 | -- | 3.65 | -- | -- | -3.88 | -3.88 | 0.00 | 15.35 | 0.00 | -- | -- | -- | -15.56 | -29.65 | -18.99 | -31.35 | -- | -45,933.33 | -- | -623,333.30 | -- | -- | 0.0128 | -- | -- | -- | 35.00 | -- | 197.79 | -- |
| Poltreg SA | 0.00 | -24.56m | 120.32m | 33.00 | -- | 2.43 | -- | -- | -5.27 | -5.27 | 0.00 | 10.61 | 0.00 | 16.45 | -- | 0.00 | -25.87 | -9.02 | -29.62 | -10.18 | -- | -659.36 | -- | -854.23 | 2.65 | -- | 0.1365 | -- | -74.98 | -6.89 | -38.06 | -- | 83.47 | -- |
| Mabion SA | 14.81m | -59.30m | 133.02m | 204.00 | -- | 1.90 | -- | 8.98 | -3.67 | -3.67 | 0.9164 | 4.33 | 0.0988 | 8.10 | 27.25 | 72,602.94 | -39.56 | 0.5366 | -54.81 | 1.06 | -178.55 | 58.34 | -400.37 | 0.9643 | 0.2276 | -- | 0.04 | -- | -54.50 | -- | -115.35 | -- | 6.00 | -- |
| Molecure SA | 5.11m | -24.42m | 159.26m | 71.00 | -- | 1.78 | -- | 31.15 | -1.20 | -1.20 | 0.2493 | 4.34 | 0.0553 | -- | 7.01 | 50,119.41 | -26.42 | -3.15 | -27.53 | -3.30 | 51.48 | 93.34 | -477.67 | -15.45 | -- | -- | 0.0588 | -- | -40.47 | 278.20 | -10.27 | -- | 12.49 | -- |
| BIOTON SA | 295.81m | -2.82m | 373.51m | 363.00 | -- | 0.6309 | 10.56 | 1.26 | -0.0329 | -0.0329 | 3.45 | 6.90 | 0.3814 | 2.02 | 8.84 | 814,906.30 | -0.3638 | 0.5935 | -0.4325 | 0.7338 | 29.69 | 41.35 | -0.954 | 2.47 | 0.5186 | 1.64 | 0.0682 | 0.00 | 14.38 | 0.561 | -788.26 | -- | -26.87 | -- |
Data as of Mar 02 2026. Currency figures normalised to Molecure SA's reporting currency: Polish New Zloty PLN
6.35%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Allianz Polska PTE SAas of 31 Dec 2024 | 700.00k | 3.40% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 603.67k | 2.93% |
| Goldman Sachs Towarzystwo Funduszy Inwestycyjnych SAas of 30 Jun 2025 | 3.70k | 0.02% |
| Rockbridge TFIas of 30 Jun 2025 | 0.00 | 0.00% |
| Allianz Polska TFI SAas of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
